Cannabinoid Receptor 2 Signaling In Neurodegenerative Disorders: From Pathogenesis To A Promising Therapeutic Target

Key Findings:  CB2 activation may be a valuable and potential alternative treatment strategy to slow the progression and reduce the symptoms of cognitive decline in AD. CB2 receptors play an important role in the pathophysiology of PD and that their activation with selective agonist may lead to neuroprotective effect in the neurodegenerative processes of PD.

Type of Study:  Meta-analysis

Study Result:  Positive

Cannabinoids Studied:  Not Applicable

Phytocannabinoid Source:  Not Applicable

Form of Administration:  Not Applicable

Study Location(s):  Italy, United Kingdom

Year of Pub:  2017

Link to study